<p>迈阿密，佛罗里达州，2026 年 2 月 26 日（全球新闻通讯社）——Soren Acquisition Corp.（纳斯达克代码：SORNU）（以下简称 “公司”）今天宣布，自 2026 年 2 月 27 日起，公司首次公开募股中发行的单位（以下简称 “单位”）的持有者，每个单位由一股面值为 0.0001 美元的公司 A 类普通股（以下简称 “A 类普通股”）和三分之一的可赎回认股权证（每个称为 “认股权证”）组成，持有者可以选择单独交易单位中包含的 A 类普通股和认股权证。分离单位时不会发行任何零碎的认股权证，只有完整的认股权证可以交易。A 类普通股和认股权证将在纳斯达克全球市场上分别以 “SORN” 和 “SORNW” 作为交易代码进行交易。未分离的单位将继续在纳斯达克全球市场上以 “SORNU” 作为交易代码进行交易。</p>
<p>BTIG, LLC 担任此次发行的唯一账簿管理人。</p>
<p>本新闻稿不构成出售公司证券的要约或购买证券的邀请，也不应在任何州或司法管辖区内进行这些证券的销售，若该要约、邀请或销售在任何此类州或司法管辖区内在未注册或未获得资格的情况下是非法的。</p>
<p><strong>关于 Soren Acquisition Corp.</strong></p>
<p>公司是一家空白支票公司，成立的目的是进行与一个或多个企业的合并、联合、股份交换、资产收购、股份购买、重组或类似的商业组合。公司可以在任何业务或行业或其公司发展阶段追求收购机会，但专注于与医疗行业内具有吸引力的目标企业完成商业组合。</p>
<p>公司的管理团队由首席执行官 Arghavan Di Rezze 和首席财务官 Jamie Weber 领导，他们都是公司董事会（以下简称 “董事会”）的成员。此外，董事会还包括 Marc Mazur、Charles N. Khan III 和 Spencer Gerrol。Peter Ondishin 和 Nicholas Shekerdemian 担任公司的顾问。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿可能包含，并且公司代表不时作出的口头声明可能包含，根据 1933 年证券法第 27A 条及 1934 年证券交易法第 21E 条的定义的 “前瞻性声明”。关于可能的商业组合及其融资的声明，以及本新闻稿中包含的所有其他非历史事实的声明均为前瞻性声明。当在本新闻稿中使用 “预期”、“相信”、“继续”、“可能”、“估计”、“期望”、“打算”、“可能”、“计划”、“潜在”、“预测”、“项目”、“应该”、“会” 等词语时，均与我们或我们的管理团队相关，标识前瞻性声明。这些前瞻性声明基于管理层的信念，以及公司管理层所做的假设和当前可用的信息。实际结果可能因某些因素而与前瞻性声明所设想的结果有实质性差异，这些因素在公司向证券交易委员会（“SEC”）提交的文件中有详细说明。所有后续的书面或口头前瞻性声明，归因于我们或代表我们行事的人，均完全受本段的限制。前瞻性声明受多种条件的制约，其中许多超出了公司的控制，包括在公司向 SEC 提交的首次公开募股注册声明和招股说明书的风险因素部分中列出的条件。除法律要求外，公司没有义务在本声明发布后的修订或更改中更新这些声明。</p>
<p><strong>公司联系方式</strong></p>
<p>Soren Acquisition Corp.</p>
<p>Arghavan Di Rezze，首席执行官</p>
<p>apd@direzzefamilyoffice.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMk1qSXpOeU0zTkRVM05UY3hJelV3TURFMU5qZzNNdz09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMk1qSXpOeU0zTkRVM05UY3hJelV3TURFMU5qZzNNdz09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDQ1NDU1MTQtYzkwNC00OGMxLWJmZmQtMDA0MmQ1Yzk4NjQxLTUwMDE1Njg3My0yMDI2LTAyLTI2LWVu/tiny/Soren-Acquisition-Corp-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDQ1NDU1MTQtYzkwNC00OGMxLWJmZmQtMDA0MmQ1Yzk4NjQxLTUwMDE1Njg3My0yMDI2LTAyLTI2LWVu/tiny/Soren-Acquisition-Corp-.png"/></p>

SORNU

<p>Soren Acquisition Corp. 宣布，从 2026 年 2 月 27 日起，其首次公开募股单位的持有者可以单独交易 A 类普通股和可赎回认股权证。A 类股票将在纳斯达克全球市场以 “SORN” 符号交易，认股权证则以 “SORNW” 符号交易。该公司专注于医疗保健收购，由首席执行官 Arghavan Di Rezze 和首席财务官 Jamie Weber 领导。此公告不构成出售证券的要约</p>

<p>Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (Nasdaq: SORNU) (the “ <strong>Company</strong>”) announced today that, commencing February 27, 2026, the holders of the units issued in the Company’s initial public offering (the “ <strong>Units</strong>”), each consisting of one Class A ordinary share of the Company, par value $0.0001 per share (the “ <strong>Class A Ordinary Shares</strong>”), and one-third of one redeemable warrant of the Company (each, a “ <strong>Warrant</strong>”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, may elect to separately trade the Class A Ordinary Shares and the Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Class A Ordinary Shares and the Warrants will trade on the Nasdaq Global Market under the symbols “SORN” and “SORNW,” respectively. Units not separated will continue to trade on the Nasdaq Global Market under the symbol “SORNU.”</p>
<div class="lb-trans"><p>迈阿密，佛罗里达州，2026 年 2 月 26 日（全球新闻通讯社）——Soren Acquisition Corp.（纳斯达克代码：SORNU）（以下简称 “公司”）今天宣布，自 2026 年 2 月 27 日起，公司首次公开募股中发行的单位（以下简称 “单位”）的持有者，每个单位由一股面值为 0.0001 美元的公司 A 类普通股（以下简称 “A 类普通股”）和三分之一的可赎回认股权证（每个称为 “认股权证”）组成，持有者可以选择单独交易单位中包含的 A 类普通股和认股权证。分离单位时不会发行任何零碎的认股权证，只有完整的认股权证可以交易。A 类普通股和认股权证将在纳斯达克全球市场上分别以 “SORN” 和 “SORNW” 作为交易代码进行交易。未分离的单位将继续在纳斯达克全球市场上以 “SORNU” 作为交易代码进行交易。</p>
</div><p>BTIG, LLC acted as sole book-running manager for the offering.</p>
<div class="lb-trans"><p>BTIG, LLC 担任此次发行的唯一账簿管理人。</p>
</div><p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>
<div class="lb-trans"><p>本新闻稿不构成出售公司证券的要约或购买证券的邀请，也不应在任何州或司法管辖区内进行这些证券的销售，若该要约、邀请或销售在任何此类州或司法管辖区内在未注册或未获得资格的情况下是非法的。</p>
</div><p><strong>About Soren Acquisition Corp.</strong></p>
<div class="lb-trans"><p><strong>关于 Soren Acquisition Corp.</strong></p>
</div><p>The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with an attractive target business within the healthcare industry.</p>
<div class="lb-trans"><p>公司是一家空白支票公司，成立的目的是进行与一个或多个企业的合并、联合、股份交换、资产收购、股份购买、重组或类似的商业组合。公司可以在任何业务或行业或其公司发展阶段追求收购机会，但专注于与医疗行业内具有吸引力的目标企业完成商业组合。</p>
</div><p>The Company’s management team is led by Arghavan Di Rezze, its Chief Executive Officer, and Jamie Weber, its Chief Financial Officer, who are both members of the Board of Directors of the Company (the “ <strong>Board</strong>”). In addition, the Board includes Marc Mazur, Charles N. Khan III and Spencer Gerrol. Peter Ondishin and Nicholas Shekerdemian serve as advisors to the Company.</p>
<div class="lb-trans"><p>公司的管理团队由首席执行官 Arghavan Di Rezze 和首席财务官 Jamie Weber 领导，他们都是公司董事会（以下简称 “董事会”）的成员。此外，董事会还包括 Marc Mazur、Charles N. Khan III 和 Spencer Gerrol。Peter Ondishin 和 Nicholas Shekerdemian 担任公司的顾问。</p>
</div><p><strong>FORWARD-LOOKING STATEMENTS</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission (“ <strong>SEC</strong>”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.</p>
<div class="lb-trans"><p>本新闻稿可能包含，并且公司代表不时作出的口头声明可能包含，根据 1933 年证券法第 27A 条及 1934 年证券交易法第 21E 条的定义的 “前瞻性声明”。关于可能的商业组合及其融资的声明，以及本新闻稿中包含的所有其他非历史事实的声明均为前瞻性声明。当在本新闻稿中使用 “预期”、“相信”、“继续”、“可能”、“估计”、“期望”、“打算”、“可能”、“计划”、“潜在”、“预测”、“项目”、“应该”、“会” 等词语时，均与我们或我们的管理团队相关，标识前瞻性声明。这些前瞻性声明基于管理层的信念，以及公司管理层所做的假设和当前可用的信息。实际结果可能因某些因素而与前瞻性声明所设想的结果有实质性差异，这些因素在公司向证券交易委员会（“SEC”）提交的文件中有详细说明。所有后续的书面或口头前瞻性声明，归因于我们或代表我们行事的人，均完全受本段的限制。前瞻性声明受多种条件的制约，其中许多超出了公司的控制，包括在公司向 SEC 提交的首次公开募股注册声明和招股说明书的风险因素部分中列出的条件。除法律要求外，公司没有义务在本声明发布后的修订或更改中更新这些声明。</p>
</div><p><strong>Company Contact</strong></p>
<div class="lb-trans"><p><strong>公司联系方式</strong></p>
</div><p>Soren Acquisition Corp.</p>
<div class="lb-trans"><p>Soren Acquisition Corp.</p>
</div><p>Arghavan Di Rezze, Chief Executive Officer</p>
<div class="lb-trans"><p>Arghavan Di Rezze，首席执行官</p>
</div><p>apd@direzzefamilyoffice.com</p>
<div class="lb-trans"><p>apd@direzzefamilyoffice.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZMk1qSXpOeU0zTkRVM05UY3hJelV3TURFMU5qZzNNdz09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTY2MjIzNyM3NDU3NTcxIzUwMDE1Njg3Mw=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDQ1NDU1MTQtYzkwNC00OGMxLWJmZmQtMDA0MmQ1Yzk4NjQxLTUwMDE1Njg3My0yMDI2LTAyLTI2LWVu/tiny/Soren-Acquisition-Corp-.png" alt="" original-src="https://ml.globenewswire.com/media/MDQ1NDU1MTQtYzkwNC00OGMxLWJmZmQtMDA0MmQ1Yzk4NjQxLTUwMDE1Njg3My0yMDI2LTAyLTI2LWVu/tiny/Soren-Acquisition-Corp-.png"/></p>

Soren Acquisition Corp.宣布其 A 类普通股和认股权证将于2026年2月27日开始分开交易 | SORN 股票新闻